FHRX First Horizon Pharmaceutical (MM)

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), a specialty pharmaceutical company, will release financial results for the first quarter ended March 31, 2006, after the market closes on Wednesday, April 26, 2006. Conference Call First Horizon will also host a conference call on Wednesday, April 26, 2006, beginning at 4:30 p.m. Eastern time to discuss the financial results and update guidance for the remainder of 2006. Analysts, investors and other interested parties are invited to participate by visiting the Company's website, http://www.fhrx.com, and entering the Investor Relations page. You may also dial in to the conference call. The dial-in numbers are 800-289-0529 for domestic callers and 913-981-5523 for international callers. All callers should use passcode 7414954 to gain access to the conference call. Please plan to dial-in or log on at least ten minutes prior to the designated start time so management can begin promptly. Replay A seven-day telephonic replay of this conference call will be available by dialing 888-203-1112 for domestic callers and 719-457-0820 for international callers. Callers should use the passcode 7414954 to gain access to the replay, which will be available through the end of the day on May 3, 2006. The replay will be available on the Investor Relations page of the Company's website for seven days. First Horizon Background First Horizon is a specialty pharmaceutical company that markets, develops and sells brand name prescription products for the primary service of cardiology and women's health. First Horizon has a portfolio that includes 15 branded products, of which eight are actively promoted to high prescribing physicians through its nationwide sales force of approximately 525 representatives. First Horizon's website address is www.fhrx.com, but information contained therein is not part of this press release.